IDIX (MM)

CAMBRIDGE, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at Needham & Company's Focus on Infectious Disease Investor Day on Thursday, November 20, 2008 at 9:00 a.m. ET at the Needham & Company Headquarters in New York, NY. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com/. Idenix Pharmaceuticals' Contacts: Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838 DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Media, Teri Dahlman, +1-617-995-9905, or Investors, Amy Sullivan +1-617-995-9838, both of Idenix Pharmaceuticals, Inc. Web Site: http://www.idenix.com/

Copyright